Metixene hydrochloride hydrate
Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
363.95
Molecular Formula
C20H26ClNOS
Notes
Research use only, not for human use.
Receptor
AChR
CAS Number
7081-40-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
